VIATRIS INC. Shareholders' Equity
VIATRIS INC. (VTRS) had Shareholders' Equity of -$201.00 million as of 2020-09-27, per its 10-Q filed 2020-11-10.
Discontinued › Balance Sheet › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2020-11-10
- 2020-09-27: Stockholders' Equity Attributable to Parent -$201.00M.
- 2020-06-28: Stockholders' Equity Attributable to Parent -$1.00M; Stockholders' Equity Attributable to Parent as first filed -$1.20M.
- 2020-03-29: Stockholders' Equity Attributable to Parent $0.00.
- 2019-12-31: Stockholders' Equity Attributable to Parent $0.00.
| Period end | Stockholders' Equity Attributable to Parent | Stockholders' Equity Attributable to Parent as first filed |
|---|---|---|
| 2020-09-27 | -$201.00M 10-Q · filed 2020-11-10 | |
| 2020-06-28 | -$1.00M 10-Q · filed 2020-11-10 | -$1.20M 10-Q · filed 2020-08-12 |
| 2020-03-29 | $0.00 10-Q · filed 2020-08-12 | |
| 2019-12-31 | $0.00 10-Q · filed 2020-11-10 | |
| 2019-09-29 | $0.00 10-Q · filed 2020-11-10 | |
| 2019-06-30 | $0.00 10-Q · filed 2020-11-10 | |
| 2019-03-31 | $0.00 10-Q · filed 2020-05-12 | |
| 2019-03-30 | $0.00 10-Q · filed 2020-08-12 | |
| 2019-02-13 | $0.00 10-Q · filed 2020-11-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| UNITED THERAPEUTICS Corp (UTHR) | United States | $20.249B | 17.64 |
| Royalty Pharma plc (RPRX) | United States | $22.628B | |
| Jazz Pharmaceuticals plc (JAZZ) | $15.333B | 16.07 | |
| Roivant Sciences Ltd. (ROIV) | $26.105B | -96.08 | |
| INSMED Inc (INSM) | United States | $26.566B | -26.60 |
| Summit Therapeutics Inc. (SMMT) | United States | $13.071B | -13.21 |
| BridgeBio Pharma, Inc. (BBIO) | United States | $12.947B | -20.72 |
| CORCEPT THERAPEUTICS INC (CORT) | United States | $12.804B | 169.10 |
| BIOMARIN PHARMACEUTICAL INC (BMRN) | United States | $11.879B | 151.80 |
| MADRIGAL PHARMACEUTICALS, INC. (MDGL) | United States | $11.859B | -38.17 |